Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2026-04-22 16:03:38 ET · period of report 2026-04-21 · accession 0001825322-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-22 16:03 | 2026-04-21 | KPTI | Rangwala Reshma | EVP, Chief Medical Off | S - Sale | $8.94 | -449 | 56.3K | -0.8% | -$4,014 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-21 | S | D | 449 | $8.94 | 56,290 | D | — | — | (F1) This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on April 4, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person. |